HEC53856

DRUG3 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Chronic Kidney DiseasesHealthyHemodialysisPeritoneal DialysisRenal Anemia

Phase 1

HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

CompletedNCT03886688

Sunshine Lake Pharma Co., Ltd.Healthy

Start: 2019-05-14End: 2020-01-01Updated: 2023-04-13

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

CompletedNCT04925661

Sunshine Lake Pharma Co., Ltd.Chronic Kidney Diseases, Renal Anemia

Start: 2021-11-04End: 2023-08-29Updated: 2025-05-15

Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.

CompletedNCT04925674

Sunshine Lake Pharma Co., Ltd.Hemodialysis, Peritoneal Dialysis

Start: 2021-09-10End: 2022-10-19Updated: 2025-05-15